2nd Quarter - Report
HOOPER, LUNDY & BOOKMAN, P.C. for AVANIR PHARMACEUTICALS, INC.
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General Medicare coverage of pharmaceutical drugs and Medicare quality programs. Medicare specialty tier cap increase.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTIN A CORRY | — |
| KELLY L. DELMORE | Legislative Assistant; Office of Phil English |
| MONICA MASSARO New | — |
Health Issues HCR
FDA labeling of pharmaceutical, general pharmaceutical issues and monitoring of 21st Century Cures Act (H.R. 6) and Innovation for Healthier Americans initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTIN A CORRY | — |
| KELLY L. DELMORE | Legislative Assistant; Office of Phil English |
| MONICA MASSARO New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.